AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 154 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $247,000 | +116.7% | 16,288 | +88.6% | 0.00% | +100.0% |
| Q4 2017 | $114,000 | -40.3% | 8,634 | -16.4% | 0.00% | -50.0% |
| Q3 2017 | $191,000 | -59.9% | 10,326 | -60.0% | 0.00% | -60.0% |
| Q2 2017 | $476,000 | -46.8% | 25,845 | -34.8% | 0.01% | -50.0% |
| Q1 2017 | $894,000 | +1296.9% | 39,657 | +2050.6% | 0.01% | +900.0% |
| Q4 2016 | $64,000 | +77.8% | 1,844 | +22.1% | 0.00% | – |
| Q2 2016 | $36,000 | -80.3% | 1,510 | -80.7% | 0.00% | -100.0% |
| Q1 2016 | $183,000 | +25.3% | 7,810 | +61.7% | 0.00% | +50.0% |
| Q4 2015 | $146,000 | +170.4% | 4,829 | +254.6% | 0.00% | +100.0% |
| Q3 2015 | $54,000 | +107.7% | 1,362 | +182.0% | 0.00% | – |
| Q1 2015 | $26,000 | -45.8% | 483 | -68.0% | 0.00% | -100.0% |
| Q3 2014 | $48,000 | +108.7% | 1,510 | +36.0% | 0.00% | – |
| Q2 2014 | $23,000 | +130.0% | 1,110 | +111.0% | 0.00% | – |
| Q1 2014 | $10,000 | – | 526 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,344,620 | $116,393,000 | 6.64% |
| Consonance Capital Management LP | 1,026,902 | $35,736,000 | 3.92% |
| FALCON POINT CAPITAL, LLC | 801,944 | $27,908,000 | 3.74% |
| Credit Capital Investments LLC | 72,813 | $2,534,000 | 3.24% |
| Crosspoint Capital Strategies, LLC | 99,274 | $3,455,000 | 3.07% |
| Camber Capital Management LP | 611,390 | $21,276,000 | 1.11% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 40,901 | $1,423,000 | 1.04% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 344,103 | $11,974,000 | 0.83% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 572,500 | $19,923,000 | 0.66% |
| AlphaOne Investment Services, LLC | 66,105 | $2,301,000 | 0.64% |